A recently identified gene, IFI44L is present in various types of tumors, including pancreatic ductal adenocarcinoma (PDAC), laryngeal cancer, hepatocellular carcinoma (HCC), and lung cancer (LC). Here, IFI44L is linked to laryngotracheoesophageal cleft.